Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
I have been reading the RNS related to the convertible bonds. Am I right in understanding that they cannot be sold until the share price reaches 25% over the issue price?
Also can they sell them as often as they like?
There is so much jargon in the RNS that it is not completely clear to me.
Hopefully Avacta have put sufficient clauses in the arrangement. I say this because bonds issued by VAST really affected the share price as the company possessing the continually dumped them whenever the price was rising.
Does he believe what he writes?
Does he think the cancer side is just hot air or something?
Does the fact that the two big players shorting closed not tell him something?
I think anyone listening to his selective and edited version of the facts would be very naive.
Are the Shorters not concerned that one or more institutional buyers could show up at any time and persuade Jupiter to close?
Where would that leave your shorts?
It may be we don’t get much news for a little while but this does not stop large investors coming in at this level, particularly once they have had chance to consider and have necessary corporate meetings following the recent investor presentations.
It cannot be denied the science here is compelling and it would only take one big buyer to mess up your shorts.
You may find yourselves in the position of those who you have recently gloated over on stocks like Odx.
Because you won’t be able to get backing if there is a large institutional buyer and Jupiter is also buying back.
I think they simply don’t believe Avacta will come good and are hoping for another bad piece of news to drive the price down more. I would not be surprised if they didn’t increase their short in an effort to stop this breaking out, particularly Jupiter.
I hope they lose, and the fund manager gets fired for being an idiot (though I’m sure they won’t)
Ninkynonk I believe the company will come good with patience but I have adjusted my expectations. I reckon most investors who are fully aware of what Avacta offers are loaded up to the neck with shares and won’t risk much more money, so we are not in a position to counter the manipulation.
I think Avacta realise they need to get more people on board to correct the share price and provide potential future investment.
I think it’s very unlikely they would seek investors if they are about to drop bad news or even switch focus away from AVA6000 as the company would likely not recover from the embarrassment.
I do however remain of the opinion that there is no news to be revealed at this roadshow, I expect very few institutional investors will be closely aware of what Avacta offers so what they do have will already seem amazing.
I also feel Avacta know the importance or raising awareness particularly now the share price is struggling.
It was not so necessary when we were on the cusp of doing well off the test which now looks much less certain. If it was a success earlier that would have greatly raised the profile of the company to II’s.
As it was not it I believe they have gone to plan B to raise awareness and bring new blood into the company, as most current Investors on here now seem like weary veterans of disappointment who have no more money or inclination to invest further, and there are not enough of us to stop the manipulation that’s going on.
I think we have had too many moments of great speculation that have led to disappointment.
I personally expect that there will be no news next week and Alistair is going to present what we already know (which is a great investment opportunity as it is) in the hope that a well done presentation will bring enough new blood into the company to stop the share price being controlled by shorters.
It may also be that they have they do have news but are keeping it under wraps with some pretext (like they are awaiting some data or a report to be finished) Then they can present the case say news is imminent present the news in a few days and they won’t be done for insider trading. Just a theory which I would be happy to be wrong on if we do get news.
Maybe they should say they will pay it back when they get HUA.
I hoped someone would disprove my theory there. The problem also could be even if we get HUA the fact it’s a s protein test may mean our tests cannot be used for flights etc because of concerns of the Omicron variant and the fact it mutates on the s spike. I would like someone to show me I’m talking rubbish with this theory please?
Is the fact that we are targeting the s protein going to count against us as it appears that France and the U.K. don’t want s protein tests. Does the fact we are not on today’s revised list mean we are going to encounter this attitude towards s protein in Europe in general?